Recent Quotes (30 days)

You have no recent quotes
chg | %

DarioHealth Corp  

(Public, NASDAQ:DRIO)   Watch this stock  
Find more results for DRIO
-0.04 (-2.37%)
Jan. 16 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 1.62 - 1.73
52 week 1.33 - 4.70
Open 1.73
Vol / Avg. 39,509.00/140,617.00
Mkt cap 17.08M
P/E     -
Div/yield     -
EPS -1.30
Shares 10.35M
Beta -1.90
Inst. own 2%
Mar. 20, 2018
Q4 2017 DarioHealth Corp Earnings Release (Estimated) Add to calendar
Nov. 14, 2017
Q3 2017 DarioHealth Corp Earnings Call
Nov. 14, 2017
Q3 2017 DarioHealth Corp Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep. '17) 2016
Net profit margin -216.58% -388.41%
Operating margin -217.02% -396.04%
EBITD margin - -372.64%
Return on average assets -147.54% -243.31%
Return on average equity -237.28% -
Employees 30 -
CDP Score - -


8 Hatokhen St.
+972-3-6222929 (Phone)
+972-4-7704059 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


DarioHealth Corp, formerly Labstyle Innovations Corp, is a digital health (mHealth) company. The Company is engaged in developing and commercializing a technology providing consumers with laboratory-testing capabilities using smart phones and other mobile devices. The Company's product, Dario, also known as Dario Smart Diabetes Management Solution, is a mobile, real-time, cloud-based, diabetes management solution based on a software application combined with a pocket-sized, blood glucose monitoring device, Dario Smart Meter. The Dario product is a digital diabetes management solution utilizing its technology delivered through a software application available for iPhone or Android and cloud-based data services with a blood glucose monitoring system device. Dario allows users to record, analyze, transmit and store various data points, such as glucose level, insulin and carbohydrate intake. It markets the Dario Smart Diabetes Management Solution in the Netherlands and New Zealand.

Officers and directors

Erez Raphael Chairman of the Board, President, Chief Executive Officer
Age: 43
Bio & Compensation  - Reuters
Zvi Ben-David Chief Financial Officer, Treasurer, Secretary
Age: 55
Bio & Compensation  - Reuters
Dror Bacher Chief Operating Officer
Age: 43
Bio & Compensation  - Reuters
Yossi Bahagon M.D. Director
Bio & Compensation  - Reuters
Yalon Farhi Director
Age: 54
Bio & Compensation  - Reuters
Allen Kamer Director
Bio & Compensation  - Reuters
Malcolm I. Hoenlein Independent Director
Age: 73
Bio & Compensation  - Reuters
Hila Karah Independent Director
Age: 48
Bio & Compensation  - Reuters